IRIX stock forecast
Our latest prediction for IRIDEX Corp.'s stock price was made on the Nov. 27, 2018 when the stock price was at 4.75$.
In the short term (2weeks), IRIX's stock price should outperform the market by 4.65%. During that period the price should oscillate between -6.72% and +14.02%.
In the medium term (3months), IRIX's stock price should outperform the market by 5.02%. During that period the price should oscillate between -15.93% and +33.68%.Get email alerts
Create a solid portfolio with IRIX
About IRIDEX Corp.
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.
At the moment the company generates 41M USD in revenues.
On its last earning announcement, the company reported a loss of -1.29$ per share.
The book value per share is 2.09$
Three months stock forecastNov. 27, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|